A single group clinical study to assess THE COMBINED EFFECTIVENESS of VRIKKASHEKHARA KASHAYA and KAISHORA GUGGULU in CHRONIC KIDNEY DISEASE (CKD)
Phase 2
- Conditions
- Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)
- Registration Number
- CTRI/2019/07/020232
- Lead Sponsor
- Ayurveda Mahavidyalaya And Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects with classical symptoms of CHRONIC KIDNEY DISEASE having the clinical features like Oedema Pruritis Generalized weakness Nausea etc.
GFR (30-100ml/min per 1.73m2)
Albuminuria
Serum creatinine (0.5-6mg/dl)
Blood urea (10-60mg/dl)
Mild Hypertension.
Subjects of both the genders.
Subjects belonging to age group between 20- 60
years of age.
Exclusion Criteria
Subjects who donâ??t fulfill the inclusion criteria will be excluded from the study.
CKD subjects of stage-4 & stage-5 are excluded.
Subjects who are on dialysis therapy.
Subjects suffering from Hepatitis/HIV/VDRL will be excluded.
Uncontrolled DM.
Hypertension above 180/110mm of Hg.
Pregnant & Lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oedema. <br/ ><br>Pruritis. <br/ ><br>Nausea. <br/ ><br>Generalized weakness. <br/ ><br>Pallor <br/ ><br>Timepoint: At the end of the 60 days clinical trial. <br/ ><br>
- Secondary Outcome Measures
Name Time Method Serum creatinine. <br/ ><br>Hb%. <br/ ><br>Urine for Albumin. <br/ ><br>Blood urea. <br/ ><br>GFR. <br/ ><br>Blood Pressure. <br/ ><br>Timepoint: At the end of 60 days of clinical trial.